Association of hepatic lipase gene polymorphisms with hypertriglyceridemia and low high-density lipoprotein-cholesterol levels among South Indian subjects without diabetes

Diabetes Technology and Therapeutics

Volumn 15, Issue 6, 2013, Pages 503-512

  Ayyappa, Kuppuswamy Ashok ^a   Ghosh, Saurabh ^b   Mohan, Viswanathan ^a   Radha, Venkatesan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTOANALYZER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE TOLERANCE; HAPLOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; URBAN POPULATION; VALIDATION PROCESS;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE INTOLERANCE; HAPLOTYPES; HUMANS; HYPERTRIGLYCERIDEMIA; INDIA; INSULIN RESISTANCE; LIPASE; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84878615799     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0302     Document Type: Article

References (46)

1. World Health Organization: Quantifying selected major risks to health. In: The World Health Report 2002 - Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization, 2002:47-97.
2. Eaton CB: Hyperlipidemia. Prim Care Clin Office Pract 2005;32:1027-1055. (Pubitemid 41739464)
3. Mather HM, Keen H: The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. BMJ 1985;291:1081-1084. (Pubitemid 16240975)
4. McKeigue PM: Coronary heart disease in Indians, Pakistanis and Bangladeshis: etiology and possibilities for prevention. Br Heart J 1992;67:341-342.
5. Mohan V, Sharp PS, Cloke JM, Burrin HR, Schumer B, Kohner EM: Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (noninsulin dependent) diabetic patients and control subjects. Diabetologia 1986;29:235-237. (Pubitemid 16107631)
6. Mohan V, Deepa R: Risk factors for coronary artery disease in Indians. J Assoc Physicians India 2004;52:95-97. (Pubitemid 44194606)
7. Joshi SR: Metabolic syndrome - emerging clusters of the Indian phenotype. J Assoc Physicians India 2003;51:445-446. (Pubitemid 41315521)
8. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C: Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-230. (Pubitemid 46805444)
9. Yajnik CS, Fall CH, Vaidya U, Pandit AN, Bavdekar A, Bhat DS, Osmond C, Hales CN, Barker DJ: Fetal growth and glucose and insulin metabolism in four-year old Indian children. Diabet Med 1995;12:330-336.
10. Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Deepa R, Babu HN, Rao MR, Mohan V: Peroxisome proliferator- activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians. Diabet Med 2005; 22:1516-1521. (Pubitemid 41641158)
11. Vimaleswaran KS, Radha V, Ramya K, Babu HN, Savitha N, Roopa V, Monalisa D, Deepa R, Ghosh S, Majumder PP, Rao MR, Mohan V: A novel association of a polymorphism in the first intron of adiponectin gene with type 2 diabetes, obesity and hypoadiponectinemia in Asian Indians. Hum Genet 2008;123:599-605.
12. Mohan V, Venkatraman JV, Pradeepa R: Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario. J Diabetes Sci Technol 2010;4:158-170.
13. Gupta R, Guptha S, Agrawal A, Kaul V, Gaur K, Gupta VP: Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population. Lipids Health Dis 2008;7:40.
14. Ramachandran A, Snehalatha C, Yamuna A, Murugesan N, Narayan KM: Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in southern India. Diabetes Care 2007;30:1828-1833. (Pubitemid 47036359)
15. Radhika G, Ganesan A, Sathya RM, Sudha V, Mohan V: Dietary carbohydrates, glycemic load and serum highdensity lipoprotein cholesterol concentrations among South Indian adults. Eur J Clin Nutr 2009;63:413-420.
16. Pradeepa R, Deepa R, Rani SS, Premalatha G, Saroja R, Mohan V: Socioeconomic status and dyslipidaemia in a South Indian population: the Chennai Urban Population Study (CUPS 11). Natl Med J India 2003;16:73-78. (Pubitemid 36722671)
17. Radha V, Mohan V, Vidya R, Ashok AK, Deepa R, Mathias RA: Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians. Am J Cardiol 2006;97:1337-1342.
18. Perret B, Mabile L, Martinez L, Tercé F, Barbaras R, Collet X: Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 2002;43:1163-1169. (Pubitemid 34988164)
19. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD: Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 2003;44: 1279-1286. (Pubitemid 37279608)
20. Brunzell J, Deeb S: Familial lipoprotein lipase deficiency, apo CII deficiency, and hepatic lipase deficiency. In: Scriver C, Beaudet A, Sly W, Vale D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 2001:2789-2816.
21. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenha?ger JC: Common C-to-T substitution at position 7480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997;17:2837-2842. (Pubitemid 28016029)
22. Hegele RA, Tu L, Connelly PW: Human hepatic lipase mutations and polymorphisms. Hum Mutat 1992;1:320-324.
23. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD: Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 1998;18:1723-1729. (Pubitemid 28521061)
24. Juo SH, Han Z, Smith JD, Colangelo L, Liu K: Promoter polymorphisms of hepatic lipase gene influence HDL2 but not HDL3 in African American men: CARDIA study. J Lipid Res 2011;42:258-264.
25. Deeb SS, Peng R: The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res 2000;41:155-158. (Pubitemid 30051854)
26. Hodoglugil U, Williamson DW, Mahley RW: Polymorphisms in the hepatic lipase gene affect plasma HDLcholesterol levels in a Turkish population. J Lipid Res 2010;51:422-430.
27. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J: Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb 2005;12:240-250.
28. Deepa M, Pradeepa R, Rema M, Anjana M, Deepa R, Shanthirani S, Mohan V: The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (Urban Component) (CURES-1). J Assoc Physicians India 2003;51:863-870. (Pubitemid 41279865)
29. Grundy SM, Cleeman JI, Merz CNB Jr, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
31. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982:149-151.
32. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265. (Pubitemid 40202029)
33. Fan Y-M, Raitakari OT, Ka?ho?nen M, Hutri-Ka?ho?nen N, Juonala M, Marniemi J, Viikari J, Lehtima? ki T: Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Genet 2009;76: 46-53.
34. Botma GJ, Verhoeven AJ, Jansen H: Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common HL gene variant, and is increased by upstream stimulatory factor. Atherosclerosis 2001;154: 625-632. (Pubitemid 32232159)
35. Pihlajamaki J, Karjalainen L, Karhapaa P: G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2000;20: 1789-1795. (Pubitemid 30470595)
36. Wood KC, Fullerton MD, El-Sohemy A, Bakovic M: Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults. Appl Physiol Nutr Metab 2008;33:761-768.
37. Kashani Farid MA, Azizi F, Hedayati M, Daneshpour MS, Shamshiri AR, Siassi F: Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study. Lipids Health Dis 2010;9:96.
38. Pollex RL, Hegele RA: Genetic determinants of plasma lipoproteins. Nat Clin Pract Cardiovasc Med 2007;4:600-609. (Pubitemid 350027165)
39. Park KW, Choi JH, Chae IH, Cho HJ, Oh S, Kim HS, Lee MM, Park YB, Choi YS: Hepatic lipase C514T polymorphism and its relationship with plasma HDL-C levels and coronary artery disease in Koreans. J Biochem Mol Biol 2003;36: 237-242. (Pubitemid 41200897)
40. Shohet RV, Vega GL, Anwar A, Cigarroa JE, Grundy SM, Cohen JC: Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol 1999;19:1975-1978. (Pubitemid 29379931)
41. Bauerfeind A, Knoblauch H, Costanza MC, Luganskaja T, Toliat MR, Nu? rnberg P, Luft FC, Reich JG, Morabia A: Concordant association of lipid gene variation with a combined HDL/LDL-cholesterol phenotype in two European populations. Hum Hered 2006;61:123-131. (Pubitemid 44385441)
42. Jansen H, Verhoeven AJM, Sijbrands JG: Hepatic lipase: a pro- or antiatherogenic protein? J Lipid Res 2002;43:1352- 1362.
43. Rader DJ: Lipid disorders. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven, 1998:59-90.
44. Cai SJ, Wong DM, Chen SH, Chan L: Structure of the human hepatic triglyceride lipase gene. Biochemistry 1989;28:8966- 8971. (Pubitemid 19283458)
45. van Hoek M, Dallinga-Thie GM, Steyerberg EW, Sijbrands EJ: Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and HL genes. Eur J Hum Genet 2009;17:1386-1393.
46. Devlin B, Roeder K, Wasserman L: Genomic control, a new approach to genetic based association studies. Theor Popul Biol 2001;60:155-166. (Pubitemid 34235086)